David Snitman Email

COO . Array BioPharma

Current Roles

Employees:
122
Revenue:
$195M
About
Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.
Array BioPharma Address
3200 Walnut Street
Boulder, CO
United States
Array BioPharma Email

Past Companies

Array BioPharmaCOO

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.